We are live on
!
Find out more
GCM
Gallacher Capital Management Portfolio holdings
AUM
$178M
1-Year Est. Return
29.29%
This Fund
S&P 500
This Quarter
Est. Return
+6.55%
1 Year Est. Return
+29.29%
3 Year Est. Return
+70.74%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$165M
AUM Growth
–
Cap. Flow
+$169M
Cap. Flow
% of AUM
102.16%
Top 10 Holdings %
Top 10 Hldgs %
38.47%
Holding
230
New
230
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FLNA
Filana Therapeutics
FLNA
|
+$21.2M |
| 2 |
PepsiCo
PEP
|
+$18.3M |
| 3 |
Yum! Brands
YUM
|
+$5.33M |
| 4 |
Vanguard Total Bond Market
BND
|
+$4.2M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$3.98M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.5% |
| 2 | Consumer Staples | 12.79% |
| 3 | Consumer Discretionary | 8.62% |
| 4 | Technology | 7.2% |
| 5 | Financials | 5.61% |
Similar funds
PS
CNWM
CCM
IAMH
SFC
WAM
SMTF
NRWA
Gallacher Capital Management's Q4 2022 Portfolio in Review
Q4 2022 is the first quarter with a 13F filing on record for Gallacher Capital Management, which disclosed 230 positions worth $165M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is Filana Therapeutics: 588,533 shares worth $17.4M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, followed by Consumer Staples and Consumer Discretionary.
- Gallacher Capital Management's largest Q4 2022 buy was Filana Therapeutics: 588,533 shares worth $17.4M.
- Gallacher Capital Management's ten largest holdings make up 38% of its $165M portfolio in Q4 2022.
- Gallacher Capital Management disclosed 230 positions in Q4 2022, its first 13F filing on record.
Based on Gallacher Capital Management's 13F filing for Q4 2022, filed 17 Jan 2023.